Product image of Muconasal Plus (Tramazoline Hydrochloride Monohydrate) supplied by GNH India

Muconasal Plus

Active Ingredient:
Tramazoline Hydrochloride Monohydrate
Origin:
EU

Muconasal Plus (Tramazoline Hydrochloride Monohydrate)

Tramazoline Hydrochloride, the active ingredient in Muconasal Plus, is a sympathomimetic amine presented as a nasal spray for nasal administration. It relieves nasal congestion associated with rhinitis and related upper‑respiratory conditions in adults and children. The formulation acts locally on the nasal mucosa to reduce swelling and improve airflow.

GNH India supplies Muconasal Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across multiple regions through rigorous quality assurance processes.

Manufacturer / TM Owner

Opella Healthcare Czech S.R.O

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Tramazoline Hydrochloride is a sympathomimetic nasal decongestant that reduces swelling of the nasal mucosa.
  • Nasal congestion: provides rapid relief of a blocked nose by constricting blood vessels in the nasal lining.
  • Allergic rhinitis: diminishes swelling and improves breathing during allergy episodes.
  • Common cold: alleviates nasal blockage associated with viral upper‑respiratory infections.

How It Works

  • Tramazoline Hydrochloride acts as an alpha‑adrenergic receptor agonist on the smooth muscle of nasal mucosal blood vessels. By stimulating α1‑adrenergic receptors, it induces vasoconstriction, which reduces vascular engorgement and edema in the nasal passages. The localized effect decreases mucus production and opens the airway without significant systemic absorption. The action is primarily confined to the nasal mucosa, minimizing systemic cardiovascular effects.

Side Effects

Tramazoline Hydrochloride may cause local and systemic adverse reactions, most of which are mild and transient.

Common Side Effects

  • Nasal irritation or burning
  • Dryness of nasal passages
  • Transient headache

Serious or Rare Side Effects

  • Elevated blood pressure or hypertension
  • Palpitations or tachycardia
  • Severe allergic reaction (anaphylaxis)

Precautions & Warnings

When using Muconasal Plus, observe the following precautions to ensure safe and effective treatment.

  • Duration of use: limit application to no more than three consecutive days to avoid rebound congestion.
  • Cardiovascular conditions: avoid in patients with uncontrolled hypertension or severe heart disease.
  • Thyroid disorders: use with caution in hyperthyroid patients.
  • Drug interactions: do not combine with other nasal decongestants or systemic sympathomimetics.
  • Pregnancy and lactation: consult a healthcare professional before use.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Tramazoline Hydrochloride can interact with certain medicines; awareness of these interactions helps prevent adverse effects.

Major Interactions (Avoid)

  • MAO inhibitors: concurrent use may cause excessive sympathomimetic effects.
  • Other nasal decongestants (e.g., oxymetazoline, phenylephrine): risk of severe hypertension and rebound congestion.

Moderate Interactions (Monitor Closely)

  • Antihypertensive agents (beta‑blockers, ACE inhibitors): may reduce blood‑pressure‑lowering effect.
  • Tricyclic antidepressants: potential additive cardiovascular stimulation.
  • Caffeine‑containing products: may increase mild stimulant effects.

Frequently Asked Questions

Muconasal Plus is indicated for the temporary relief of nasal congestion associated with allergic rhinitis, the common cold, and other upper‑respiratory conditions. It works by narrowing blood vessels in the nasal lining, which reduces swelling and improves airflow.

Tramazoline Hydrochloride is an alpha‑adrenergic agonist. When applied to the nasal mucosa it stimulates α1‑adrenergic receptors on the smooth muscle of nasal blood vessels, causing vasoconstriction. This reduces mucosal edema, limits mucus formation, and opens the nasal passages.

The dosage of Muconasal Plus is determined by a qualified healthcare professional based on the patient’s age, condition, and response. Typically, a few sprays per nostril are used, but the exact regimen should follow the prescriber’s instructions and the product label.

Safety data for Tramazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the Muconasal Plus product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Muconasal Plus contains Tramazoline Hydrochloride, a sympathomimetic amine similar in action to oxymetazoline or phenylephrine. It offers rapid vasoconstriction with a short duration of effect. Compared with some alternatives, it may have a slightly lower incidence of rebound congestion when used within recommended limits.

Store Muconasal Plus at room temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture, direct sunlight, and extreme heat. Do not freeze the product, and retain it in its original packaging until use.

Muconasal Plus is applied intranasally. The user should gently blow the nose, remove the protective cap, and spray the recommended number of sprays into each nostril while keeping the head upright. Avoid inhaling deeply during administration to limit systemic absorption.

Serious adverse reactions, though rare, include significant elevation of blood pressure, tachycardia, severe allergic reactions such as anaphylaxis, and nasal septum perforation with misuse. Patients should discontinue use and seek medical attention if they experience these symptoms.

Muconasal Plus should be avoided in individuals with uncontrolled hypertension, severe cardiovascular disease, hyperthyroidism, known hypersensitivity to Tramazoline Hydrochloride or any excipients, and in children under the age recommended on the product label. Consultation with a healthcare professional is essential before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Tramazoline Hydrochloride Monohydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT